Cell-based Assays
With a long-standing commercial track record in cell-based research, we have established a wide range of cell-based assay options, and we cover both established assays and assay development.
We offer
- A broad choice of cell lines and primary models, covering multiple disease indications (oncology, metabolic diseases, cardiovascular etc.), plus custom stable cell lines
- Specialist expertise in the oncology context, including immuno-oncology assays
- Compound and combination treatments, up to small libraries
- Deep understanding and experience in gene silencing assays using shRNAs and siRNAs
- Standard and custom homogenous plate reader assays (proliferation, apoptosis etc.)
- Label-free impedance measurements
- Fixed-endpoint and live high-content microscopy assays
- Confocal microscopy and FACS analyses
- Single and multiplexed RT-qPCR assays; Quantstudio platform for pre-designed or custom panels of up to 900 genes
- Add-on protein profiling assays (e.g., cellular pathway mapping, cytokines from cell supernatants)
